整合疗效与安全性的结局方阵用于功能性垂体腺瘤手术
本研究提出一种在患者层面整合疗效与安全性的结局分类与报告新方法,并回顾性分析2010至2018年单中心198例纯内镜经蝶手术(含44例再手术)。按经典标准 remission 为127例(64%),良好结局121例(61%),不良结局6例(3%);若以手术预期效果替代 remission,则良好结局148例(75%),不良结局4例(2%)。
要点
- 结局方阵将疗效与安全性整合为良好至不良4类,便于患者层面报告。
- 198例功能性垂体腺瘤手术中,remission 127例(64%),良好结局121例(61%)。
- 以手术预期效果替代 remission 时,良好结局148例(75%),不良结局4例(2%)。
核心结论
- 手术质量可用4个简单类别呈现,整合疗效与安全性,并可灵活适应患者、疾病、手术策略及关注结局。
研究设计与样本
- 回顾性 chart review,纳入2010至2018年单三级转诊中心所有纯内镜经蝶手术治疗肢端肥大症、库欣病和泌乳素瘤的手术。
- 共纳入198次手术,其中44次为再手术。
主要发现
- remission 在127次手术(64%)中实现。
- 良好结局见于121次手术(61%),不良结局见于6次手术(3%)。
- 以手术预期效果替代 remission 时,198次手术中良好结局148次(75%),不良结局4次(2%)。
关键数值与推荐
- 结局方阵整合预期效应与不良效应(长期并发症),形成从良好到不良的4个结局组。
临床怎么用
- 临床可采用结局方阵在患者层面同时报告疗效与安全性,替代单纯切除程度和并发症率的单维报告。
局限性
- 回顾性 chart review,单中心,仅纳入纯内镜经蝶手术的功能性垂体腺瘤病例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Transsphenoidal surgery is standard care in the treatment of hormone-secreting pituitary adenomas. Current clinician-reported surgical outcome measures are one-dimensional, typically focusing primarily on complete or partial resection, and secondarily on complication rates. However, outcomes are best reflected by the delicate balance of efficacy and complications at patient level. OBJECTIVE: This study proposes a novel way to classify and report outcomes, integrating efficacy and safety at the patient level. METHODS: Retrospective chart review of all pure endoscopic transsphenoidal surgical procedures for acromegaly, Cushing's disease, and prolactinoma between 2010 and 2018 in a single tertiary referral center. We present our results in a classic (remission and complications separate) and in a novel outcome square integrating both outcomes, focusing on intended and adverse effects (long-term complications). This resulted in 4 outcome groups, ranging from good to poor. We use this approach to present these outcomes for several subgroups. RESULTS: A total of 198 surgical procedures were included (44 reoperations). Remission was achieved in 127 operations (64%). Good outcome was observed after 121 (61%), and poor outcome after 6 (3%) operations. When intended effect of surgery was applied (instead of remission), good outcome as intended was achieved after 148 of 198 surgeries (75%) and poor outcome after 4 (2%). CONCLUSION: Quality of a surgical intervention can be presented in 4 simple categories, integrating both efficacy and safety with flexibility to adapt to the individualized situation at patient, disease, and surgical strategy and to the outcome of interest.
引用
- de Vries F, Lobatto DJ, Verstegen MJT, et al. Outcome Squares Integrating Efficacy and Safety, as Applied to Functioning Pituitary Adenoma Surgery. J Clin Endocrinol Metab. 2021. PMID: 33693739. doi:10.1210/clinem/dgab138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。